Clene Nanomedicine (CLNN) - Earnings per share increase in current year
The annual growth of net income per share in percentage terms, which forms this chart via GURU.Markets data, is based on Clene Inc. (CLNN) unique nanosuspension patents and strict FDA oversight. A team of elite nanotechnologists strives to defeat neurodegeneration, yet the 17.80 metric determines this level. Meanwhile, a critical liquidity deficit and the risk of regulatory rejection create significant uncertainty for investors.
Comprehensive metric breakdowns and analytics for clene.com (CLNN)
- stock value and consensus price forecast:
- market capitalization indicators:
- business book valuation details:
- debt burden and liquidity indicators:
- earnings and multiples data:
CLNN - Company Net Income|Net Profit Forecast Clene Inc.|CLNN - Price to Earnings Ratio|Price to Future Earnings Ratio Clene|CLNN - PEG Multiple|Company Value to EBITDA Clene Inc.|CLNN - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Clene|CLNN - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months clene.com|CLNN - Earnings per share growth in current year|Expected net earnings per share growth next year Clene Inc.
Fundamental valuation:CLNN, Clene Nanomedicine
This indicator measures the year-over-year dynamics of net earnings per share. Tracking annual EPS growth allows for the rapid identification of changes in the issuer's financial stability. The calculation is based on a comparison of current results with the same period last year to identify profitability trends. For Clene Inc. (CLNN), this metric is critical due to the high capital burn associated with the development of nanotechnologies. Negative dynamics here directly reflect risks linked to clinical trial uncertainty and dependence on FDA approval.
Main competitors
Earnings per share growth rate in current year Biogen Inc (BIIB)|Net earnings per share growth this year NBIX|RGC: Earnings per share increase in current year|Earnings growth in current year AXSM|Expected net earnings per share growth this year acadia-pharm.com|Earnings per share growth in current year Xenon XENE|VKTX: Earnings per share growth this year|Supernus Pharma - Earnings growth in current year|Catalyst Corp (CPRX) - Net earnings per share growth this year|DNLI (Denali Therapeutics) - Net earnings per share growth this year|HRMY - Expected net earnings per share growth this year|BHVN (Biohaven) - Earnings growth in current year|Net earnings per share growth this year Amylyx Pharmaceuticals Inc (AMLX)|Earnings per share growth in current year Trevi Pharma (TRVI)|Earnings per share growth in current year PRAX (Praxis Corp)|Earnings per share growth in current year Anavex Life Sciences AVXL|CBLL: Earnings per share growth this year|PRTA - Earnings per share growth in current year|ALEC (Alector, Inc.) - Earnings per share growth this year|Annexon Inc. (ANNX) - Earnings per share growth in current year|Earnings per share growth this year OMER|NGNE (Neurogene Inc.) - Earnings growth in current year|Earnings per share growth rate in current year acimmune.com ACIU|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Earnings growth in current year Neumora (NMRA)|Earnings per share growth in current year Scilex Holding Co. SCLX|Earnings per share increase in current year TVGN|ACOG - Earnings per share growth in current year|Earnings per share growth rate in current year Cognition Therapeutics Inc.|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences Inc|Earnings per share growth in current year Assertio Holdings|Earnings per share growth in current year COYA|Earnings growth in current year VTGN|OVID - Earnings per share growth rate in current year|Earnings per share growth in current year Acumen Pharmaceuticals, Inc. ABOS|CRVO: Earnings per share growth this year|Alterity Therapeutics Ltd - Earnings growth in current year|Earnings per share growth rate in current year PepGen Inc.|JUNS (Jupiter Neurosciences) - Net earnings per share growth this year|relmada.com - Earnings per share increase in current year|ANVS (Annovis Bio) - Earnings growth in current year|Grace Tx (GRCE) - Expected net earnings per share growth this year|Earnings per share growth in current year Firefly Neuroscience Inc (AIFF)|anewmeds.com - Earnings per share growth this year|Earnings growth in current year NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Net earnings per share growth this year|MTVA: Net earnings per share growth this year|Expected net earnings per share growth this year NeurAxis Inc. NRXS|HSDT: Earnings growth in current year|Net earnings per share growth this year Passage Bio|Earnings per share growth in current year Neuphoria Therapeutics, Inc.|Earnings per share growth in current year NERV|Earnings per share growth in current year Athira Pharma (ATHA)|Addex Therapeutics Ltd. - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro ALZN|CYCN: Earnings per share growth this year|PTIX - Earnings per share growth in current year|KTTA (Pasithea Therapeutics) - Earnings per share growth this year|CRGT: Earnings growth in current year|Earnings per share growth rate in current year Avenue Therapeutics Inc. (ATXI)|Net earnings per share growth this year BCLI|Earnings growth in current year Cara Therapeutics Inc|Earnings per share growth in current year Chromocell Therapeutics (CHRO)|ELYM (eliemtx.com) - Earnings per share increase in current year|Earnings per share growth in current year Intra-Cellular Therapies, Inc. ITCI|Longboard Pharmaceuticals Inc (LBPH) - Earnings per share growth rate in current year|Marinus - Earnings growth in current year|NKGen Biotech Corp (NKGN) - Net earnings per share growth this year|NeuroBo Pharmaceuticals (NRBO) - Earnings per share growth in current year|SAGE (sagerx.com) - Earnings per share growth in current year|SNPX (Synaptogenix) - Earnings growth in current year|Earnings per share growth rate in current year Trevena Inc. TRVN|Earnings per share growth in current year Vigil Neuroscience (VIGL)|anewmeds.com - Earnings per share growth this year|Earnings growth in current year CERE (Cerevel Therapeutics)
